TgAb have been proposed as tumor markers in DTC. Recent evidence links TgAb levels with DTC aggressiveness. We aimed to evaluate the relationship between TgAb and tumor glucose metabolism in DTC patients.
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications
Morbelli, S;Ferrarazzo, G;Pomposelli, E;Pupo, F;PESCE, GIAMPAOLA;Calamia, I;Fiz, F;Clapasson, A;Bauckneht, M;MINUTO, MICHELE;SAMBUCETI, GIANMARIO;GIUSTI, MASSIMO;BAGNASCO, MARCELLO
2017-01-01
Abstract
TgAb have been proposed as tumor markers in DTC. Recent evidence links TgAb levels with DTC aggressiveness. We aimed to evaluate the relationship between TgAb and tumor glucose metabolism in DTC patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
morbelli2016.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
595.29 kB
Formato
Adobe PDF
|
595.29 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
